In pancreatic cancers, glucose-activated O-GlcNAc modification of ZEB1 at Ser555 enhances its stabilization and nuclear translocation, thus decreasing lipid peroxidation and ferroptosis in mesenchymal pancreatic cancer cells (Table 1) (Wang et al., 2022). Here, ZEB1 is linked to pancreatic neoplasm.